Remove Antibody Remove Genotoxicity Remove Protein Remove RNA
article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

Beyond our expertise in small molecules, we have built a solid reputation with biopharmaceutical companies for the characterisation and analysis of monoclonal antibodies, therapeutic proteins and biosimilars. Ribonucleic acid (RNA) based technologies are among many innovative approaches explored to tackle the Covid-19 pandemic.